Towa Pharmaceutical

Towa Pharmaceutical

World Rank (Jan-05-2024)
9,674
Market Cap (Jan-05-2024)
0.817 Billion USD
World Rank (Jul-30-2023)
11,308
Market Cap (Jul-30-2023)
0.629 Billion USD
World Rank (Jan-07-2022)
8,326
Market Cap (Jan-07-2022)
1.243 Billion USD
World Rank (Jan-01-2021)
8,324
Market Cap (Jan-01-2021)
0.914 Billion USD
Headquarters Country
Japan
Market Cap (Mar-08-2026)
1.31
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
1,208 Million USD
Annual Net Income in USD
116 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
2,408 Million USD
Total Liabilities in USD
1,443 Million USD
Total Equity in USD
964 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
TOWA PHARMACEUTICAL
Yahoo
Yahoo @ Tokyo
Company Profile
Towa Pharmaceutical manufactures and distributes pharmaceutical products and it focused on the products like neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins and hormone drugs. The company annual revenue is 154,900 million JPY and annual net income is 13,958 million JPY for year ending March 2021. The headquarters is in Japan.
Stock Exchange
Tokyo

Share